ERS Genomics appoints vice-president of IP
23-09-2020
Broad Institute presses for CRISPR settlement after EPO revocation
23-01-2020
Broad hits out at UC Berkeley in latest CRISPR battle
02-08-2019
Ken Wolter / Shutterstock.com
The Broad Institute and ERS Genomics, a company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, have both claimed victory in the latest round of the CRISPR inventorship battle.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
PTAB, USPTO, CRISPR, Broad Institute, UC Berkeley, MIT, Harvard, CRISPR Cas9, patent, genome editing, inventorship, ERS Genomics
